11-28113392-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001113528.2(METTL15):c.58G>A(p.Glu20Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000401 in 1,595,110 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113528.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
METTL15 | NM_001113528.2 | c.58G>A | p.Glu20Lys | missense_variant | 3/7 | ENST00000407364.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
METTL15 | ENST00000407364.8 | c.58G>A | p.Glu20Lys | missense_variant | 3/7 | 5 | NM_001113528.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151854Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000539 AC: 13AN: 241250Hom.: 0 AF XY: 0.0000766 AC XY: 10AN XY: 130610
GnomAD4 exome AF: 0.0000423 AC: 61AN: 1443256Hom.: 2 Cov.: 28 AF XY: 0.0000530 AC XY: 38AN XY: 717010
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151854Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74144
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.58G>A (p.E20K) alteration is located in exon 3 (coding exon 1) of the METTL15 gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glutamic acid (E) at amino acid position 20 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at